Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17097682rdf:typepubmed:Citationlld:pubmed
pubmed-article:17097682lifeskim:mentionsumls-concept:C0015576lld:lifeskim
pubmed-article:17097682lifeskim:mentionsumls-concept:C1556094lld:lifeskim
pubmed-article:17097682lifeskim:mentionsumls-concept:C1711254lld:lifeskim
pubmed-article:17097682lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:17097682lifeskim:mentionsumls-concept:C0206245lld:lifeskim
pubmed-article:17097682lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:17097682lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:17097682lifeskim:mentionsumls-concept:C2348519lld:lifeskim
pubmed-article:17097682pubmed:issue1lld:pubmed
pubmed-article:17097682pubmed:dateCreated2006-12-20lld:pubmed
pubmed-article:17097682pubmed:abstractTextFamilial amyloid polyneuropathy (FAP: type IV), known as familial amyloidosis of the Finnish type (FAF), is very rare and reported only in a few countries. The gelsolin mutation G654A is most frequent causative gene in FAF family. The clinical phenotype of FAF possesses several neurological characteristics with multiple cranial nerve signs, in addition to a peculiar exanthema of "lichen amyloidosus" and pendulous skin "cutis laxa", and the carpal tunnel syndrome. We report a new Japanese FAF family presenting bilateral atrophies and fasciculations of the facial muscles and tongue. The patients in our family presented with skin changes as "lichen amyloidosus" and "cutis laxa". In this FAF family, lichen amyloidosus appeared under sunlight and high temperatures in the summer season every year. Two patients in our family presented with common clinical features of FAF, except for the above laboratory results. Including previous cases and our family, this clinical phenotype is similar to the gelsolin gene mutation (G654A) in FAF family members.lld:pubmed
pubmed-article:17097682pubmed:languageenglld:pubmed
pubmed-article:17097682pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17097682pubmed:citationSubsetIMlld:pubmed
pubmed-article:17097682pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17097682pubmed:statusMEDLINElld:pubmed
pubmed-article:17097682pubmed:monthJanlld:pubmed
pubmed-article:17097682pubmed:issn0022-510Xlld:pubmed
pubmed-article:17097682pubmed:authorpubmed-author:SasakiAtsushi...lld:pubmed
pubmed-article:17097682pubmed:authorpubmed-author:OkamotoKoichi...lld:pubmed
pubmed-article:17097682pubmed:authorpubmed-author:IkedaMasakiMlld:pubmed
pubmed-article:17097682pubmed:authorpubmed-author:WatanabeMitsu...lld:pubmed
pubmed-article:17097682pubmed:authorpubmed-author:FujitaYukioYlld:pubmed
pubmed-article:17097682pubmed:authorpubmed-author:NakamuraMoton...lld:pubmed
pubmed-article:17097682pubmed:authorpubmed-author:OtaniTomohiro...lld:pubmed
pubmed-article:17097682pubmed:authorpubmed-author:TakatamaMasam...lld:pubmed
pubmed-article:17097682pubmed:authorpubmed-author:MizushimaKazu...lld:pubmed
pubmed-article:17097682pubmed:authorpubmed-author:MakiokaKoukiKlld:pubmed
pubmed-article:17097682pubmed:authorpubmed-author:EnokiMarikoMlld:pubmed
pubmed-article:17097682pubmed:issnTypePrintlld:pubmed
pubmed-article:17097682pubmed:day15lld:pubmed
pubmed-article:17097682pubmed:volume252lld:pubmed
pubmed-article:17097682pubmed:ownerNLMlld:pubmed
pubmed-article:17097682pubmed:authorsCompleteYlld:pubmed
pubmed-article:17097682pubmed:pagination4-8lld:pubmed
pubmed-article:17097682pubmed:meshHeadingpubmed-meshheading:17097682...lld:pubmed
pubmed-article:17097682pubmed:meshHeadingpubmed-meshheading:17097682...lld:pubmed
pubmed-article:17097682pubmed:meshHeadingpubmed-meshheading:17097682...lld:pubmed
pubmed-article:17097682pubmed:meshHeadingpubmed-meshheading:17097682...lld:pubmed
pubmed-article:17097682pubmed:meshHeadingpubmed-meshheading:17097682...lld:pubmed
pubmed-article:17097682pubmed:meshHeadingpubmed-meshheading:17097682...lld:pubmed
pubmed-article:17097682pubmed:meshHeadingpubmed-meshheading:17097682...lld:pubmed
pubmed-article:17097682pubmed:meshHeadingpubmed-meshheading:17097682...lld:pubmed
pubmed-article:17097682pubmed:meshHeadingpubmed-meshheading:17097682...lld:pubmed
pubmed-article:17097682pubmed:meshHeadingpubmed-meshheading:17097682...lld:pubmed
pubmed-article:17097682pubmed:meshHeadingpubmed-meshheading:17097682...lld:pubmed
pubmed-article:17097682pubmed:meshHeadingpubmed-meshheading:17097682...lld:pubmed
pubmed-article:17097682pubmed:meshHeadingpubmed-meshheading:17097682...lld:pubmed
pubmed-article:17097682pubmed:year2007lld:pubmed
pubmed-article:17097682pubmed:articleTitleFamilial amyloid polyneuropathy (Finnish type) in a Japanese family: Clinical features and immunocytochemical studies.lld:pubmed
pubmed-article:17097682pubmed:affiliationDepartment of Neurology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan. mikeda@med.gunma-u.ac.jplld:pubmed
pubmed-article:17097682pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17097682lld:pubmed